An open labeled clinical trail on the effect of Vrikshamla in Sthaulya (obesity) w.s.r to hyperlipidaemia

Ishwarayya S Mathapati, M. R.
{"title":"An open labeled clinical trail on the effect of Vrikshamla\nin Sthaulya (obesity) w.s.r to hyperlipidaemia","authors":"Ishwarayya S Mathapati, M. R.","doi":"10.21760/jaims.5.1.4","DOIUrl":null,"url":null,"abstract":"Obesity is one of the leading cause for more than 53 diseases and in India around 30 million peoples\nare suffering with Sthaulya (obesity), individual habits with stressful life, wrong dietary habits and\nsedentary life is the main cause of disease and no satisfactory treatment is available in conventional\nsystem. Hence there is need explore alternative system of Indian medicine like Ayurveda for the\nbenefits of sufferers Ayurveda dealt this disease as Sthaulya (obesity) under Medoroga (Adipose tissue\ndisorder) and many treatment modalities have been explained number of drugs in Brahatrayi\n(Charaka, Sushruta and Vagbhat) were cited Bhavamishra was the author of Bhavaprakash Nighantu\n(Lexicon) which is one of the Laghutrayis (Sharanghadara, Madhavanidhana and Bhavaprakash) text is\nhighlighted with Karmaoushadi (action based drug) such as Amradi Phala Varga explained Vrikshamla\nconsidered as drug index of Ayurveda, thus present study was designed to screen the drug with\nproperties of Kapha Medohara (ability to reduce Kapha and Fat), Medorogahara (reduces Adipose\ntissue), Sthaulyanashaka (Anti obesity) and Karshyakara (ability to make lean) from Bhavaprakasha\nNighantu in Ayurveda.","PeriodicalId":153289,"journal":{"name":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","volume":"85 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda and Integrated Medical Sciences (JAIMS)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21760/jaims.5.1.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Obesity is one of the leading cause for more than 53 diseases and in India around 30 million peoples are suffering with Sthaulya (obesity), individual habits with stressful life, wrong dietary habits and sedentary life is the main cause of disease and no satisfactory treatment is available in conventional system. Hence there is need explore alternative system of Indian medicine like Ayurveda for the benefits of sufferers Ayurveda dealt this disease as Sthaulya (obesity) under Medoroga (Adipose tissue disorder) and many treatment modalities have been explained number of drugs in Brahatrayi (Charaka, Sushruta and Vagbhat) were cited Bhavamishra was the author of Bhavaprakash Nighantu (Lexicon) which is one of the Laghutrayis (Sharanghadara, Madhavanidhana and Bhavaprakash) text is highlighted with Karmaoushadi (action based drug) such as Amradi Phala Varga explained Vrikshamla considered as drug index of Ayurveda, thus present study was designed to screen the drug with properties of Kapha Medohara (ability to reduce Kapha and Fat), Medorogahara (reduces Adipose tissue), Sthaulyanashaka (Anti obesity) and Karshyakara (ability to make lean) from Bhavaprakasha Nighantu in Ayurveda.
一项开放标签的临床试验,研究肥胖药对高脂血症的影响
肥胖是超过53种疾病的主要原因之一,在印度,大约有3000万人患有Sthaulya(肥胖),压力生活的个人习惯,错误的饮食习惯和久坐不动的生活是导致疾病的主要原因,在传统系统中没有令人满意的治疗方法。因此,有必要探索印度医学的替代系统,如阿育吠陀,以患者的利益。阿育吠陀将这种疾病作为肥胖(肥胖)在Medoroga(脂肪组织紊乱)下,许多治疗方式已经得到解释,许多药物在Brahatrayi(Charaka, Sushruta和Vagbhat)被引用。Bhavamishra是Bhavaprakash Nighantu(词典)的作者,这是Laghutrayis (Sharanghadara)之一。如Amradi Phala Varga将vrikshamlaca解释为阿育吠陀的药物指数,因此本研究旨在筛选阿育吠陀BhavaprakashaNighantu中具有Kapha Medohara(减少Kapha和脂肪的能力),Medorogahara(减少脂肪组织),Sthaulyanashaka(抗肥胖)和Karshyakara(制造瘦的能力)特性的药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信